O’Donnell, M. E., Badger, S. A., Beattie, G. C., Carson, J. & Garstin, W. I. Malignant neoplasms of the appendix. Int. J. Colorectal Dis. 22, 1239–1248 (2007).
Singh, H., Koomson, A. S., Decker, K. M., Park, J. & Demers, A. A. Continued increasing incidence of malignant appendiceal tumors in Canada and the United States: a population-based study. Cancer 126, 2206–2216 (2020).
Marmor, S., Portschy, P. R., Tuttle, T. M. & Virnig, B. A. The rise in appendiceal cancer incidence: 2000-2009. J. Gastrointest. Surg. 19, 743–750 (2015).
Trivedi, A. N., Levine, E. A. & Mishra, G. Adenocarcinoma of the appendix is rarely detected by colonoscopy. J. Gastrointest. Surg. 13, 668–675 (2009).
Soto Llanes, J. O., Dosal Limon, S. K., Iberri Jaime, A. J., Zambrano Lara, M. & Jimenez Bobadilla, B. Lower gastrointestinal bleeding secondary to appendiceal mucinous neoplasm: a report of two cases and a review of the literature. Cureus 16, e52908 (2024).
PubMed PubMed Central Google Scholar
Xie, M. & Li, F. Incidental diagnosis of primary appendiceal signet-ring cell adenocarcinoma after appendectomy for acute appendicitis: a case report. Ann. Med. Surg. 86, 3117–3122 (2024).
Votanopoulos, K. I., Shen, P., Skardal, A. & Levine, E. A. Peritoneal metastases from appendiceal cancer. Surg. Oncol. Clin. N. Am. 27, 551–561 (2018).
Article PubMed PubMed Central Google Scholar
Janczewski, L. M. et al. Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer. CA Cancer J. Clin. 73, 590–596 (2023). This article highlights key clinical components of the published version 9 of the AJCC staging system for appendiceal tumours.
Holowatyj, A. N. et al. Early-onset appendiceal cancer survival by race or ethnicity in the United States. Gastroenterology 159, 1605–1608 (2020).
Gibbs, T. et al. Histologic and racial/ethnic patterns of appendiceal cancer among young patients. Cancer Epidemiol. Biomark. Prev. 30, 1149–1155 (2021). This population-based cohort study defines appendiceal tumour features among young patients, including the discovery that approximately one in every three adult patients is diagnosed with early-onset disease (before the age of 50 years).
Chauhan, A. et al. AJCC Cancer Staging System: Neuroendocrine Tumors of the Appendix (American College of Surgeons, 2023).
National Comprehensive Cancer Network. NCCN guidelines: neuroendocrine and adrenal tumors. NCCN https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1448 (2024).
McMillan, S. S., King, M. & Tully, M. P. How to use the nominal group and Delphi techniques. Int. J. Clin. Pharm. 38, 655–662 (2016).
PubMed PubMed Central Google Scholar
Valasek, M. A. et al. Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care. PLoS ONE 12, e0179216 (2017). This study reveals a 28.3% overall discordance in the pathological classification of appendiceal tumours (inclusive of LAMNs and adenocarcinomas) between the originating, outside pathology group and the in-house pathology review at a single large academic medical centre, highlighting the critical need for expert pathology review of appendix tumours among all patients.
Article PubMed PubMed Central Google Scholar
Overman, M. J. et al. AJCC Cancer Staging System: Appendix (American College of Surgeons, 2023).
Maedler, C. et al. Goblet cell carcinoid of the appendix — an interobserver variability study using two proposed classification systems. Ann. Diagn. Pathol. 32, 51–55 (2018).
Nagtegaal, I. D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 76, 182–188 (2020). The fifth edition of the WHO classification of tumours of the digestive system reflects the change in classification from goblet cell carcinoid or carcinoma to goblet cell adenocarcinoma of the appendix, given that the recognition of this tumour type has a minor neuroendocrine component.
National Cancer Institute, Surveillance, Epidemiology, and End Results Program. US county population data (1969–2022). SEER www.seer.cancer.gov/popdata (2024).
Miller, L. D. & Votanopoulos, K. I. Exploring the relationship: low-grade appendiceal mucinous neoplasms (LAMN) and mucinous adenocarcinoma as phases of the same disease spectrum. Ann. Surg. Oncol. 30, 6976–6977 (2023).
PSM Appendiceal Tumor Writing Group, PSM Consortium Group & Turaga, K. K. Consensus guideline for the management of patients with appendiceal tumors: part 1: appendiceal tumors with peritoneal involvement. Preprint at medRxiv https://doi.org/10.1101/2024.04.09.24305468 (2024).
PSM Appendiceal Tumor Writing Group, PSM Consortium Group & Turaga, K. K. Consensus guideline for the management of patients with appendiceal tumors: part 2: appendiceal tumors without peritoneal involvement. Preprint at medRxiv https://doi.org/10.1101/2024.08.30.24309032 (2024).
Overman, M. J. et al. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann. Surg. 257, 1072–1078 (2013).
SenthilKumar, G. et al. Validation of the AJCC 8th edition staging system for disseminated appendiceal cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a multi-institutional analysis. Ann. Surg. Oncol. 30, 5743–5753 (2023).
Davison, J. M. et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod. Pathol. 27, 1521–1539 (2014).
Bradley, R. F., Stewart, J. H. T., Russell, G. B., Levine, E. A. & Geisinger, K. R. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am. J. Surg. Pathol. 30, 551–559 (2006).
Ronnett, B. M. et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am. J. Surg. Pathol. 19, 1390–1408 (1995).
Article CAS PubMed Google Scholar
Carr, N. J. et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am. J. Surg. Pathol. 40, 14–26 (2016).
Alakus, H. et al. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 6, 43 (2014).
Article PubMed PubMed Central Google Scholar
Raghav, K. et al. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Br. J. Cancer 123, 1262–1270 (2020).
Article CAS PubMed PubMed Central Google Scholar
Ang, C. S. et al. Genomic landscape of appendiceal neoplasms. JCO Precis. Oncol. 2, 1–18 (2018).
Tokunaga, R. et al. Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer. Clin. Cancer Res. 25, 3096–3103 (2019). This study analyses next-generation sequencing data from a commercial laboratory of appendiceal adenocarcinomas and right-sided and left-sided colorectal tumours, highlighting molecular differences between the two tumour types, going some way towards improving personalized treatment strategies for this rare tumour type.
Article CAS PubMed PubMed Central Google Scholar
Levine, E. A. et al. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J. Am. Coll. Surg. 214, 599–606 (2012).
Article PubMed PubMed Central Google Scholar
Morgan, R. B. et al. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J. Surg. Oncol. 127, 831–840 (2023).
Article CAS PubMed Google Scholar
Liu, X. et al. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clin. Chem. 60, 1004–1011 (2014).
Article CAS PubMed Google Scholar
Borazanci, E. et al. Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. J. Gastrointest. Oncol. 8, 164–172 (2017).
Article PubMed PubMed Central Google Scholar
Kabbani, W., Houlihan, P. S., Luthra, R., Hamilton, S. R. & Rashid, A. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod. Pathol. 15, 599–605 (2002).
Nishikawa, G. et al. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br. J. Cancer 108, 951–958 (2013).
Article CAS PubMed PubMed Central Google Scholar
Munari, G. et al. Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience. J. Cancer Res. Clin. Oncol. 147, 1897–1904 (2021).
Comments (0)